a Better Bubble™

EQ

Arch Grants Awards $1.7 Million to 20 Startups

6 days 17 hours ago

Arch Grants has awarded $1.7 million in non-dilutive grants to 20 startups, constituting the nonprofit’s 2024 Cohort. Over 300 volunteer judges selected from over 550 applicants to Arch Grants’ annual Startup Competition, each awardee has committed to being headquartered in St. Louis for at least one year. 

The post Arch Grants Awards $1.7 Million to 20 Startups appeared first on EQ.

Jonathan Allen

How Saint Louis Zoo’s Wildcare Park Benefits Our Region

6 days 18 hours ago

Mike Fabrizi examines the forthcoming Wildcare Park’s impacts on our region.

Some of these are economic, which stem from the construction project itself, increased Zoo operations, spending by visitors, more tax revenue, and increased property values.

In addition to economic impacts, however, there are also the benefits stemming from enhancing our region’s “creative community”. They make our Saint Louis an even more attractive place in which to live, and tend to attract the “creative” and “entrepreneurial” classes, as do other cultural and civic institutions.

The post How Saint Louis Zoo’s Wildcare Park Benefits Our Region appeared first on EQ.

Mike Fabrizi

Active Pharmaceuticals Ingredients Innovation Center (APIIC) is Reshoring a Vital Industry and Restoring Health Security

1 week 5 days ago

As part of EQ’s building a contextual map of the St. Louis innovation and entrepreneurial scene, we interviewed Anthony Sardella, the Chairman and CEO of the Active Pharmaceuticals Ingredients Innovation Center (hereafter referred to as the API Innovation Center), an independent business leveraging our region’s bioscience and manufacturing strengths to solve a vital twenty-first century challenge. We thank Tony and his staff for generously sharing with us their expertise, their enthusiasm for the API Innovation Center’s mission, and their assistance with this narrative. What follows stems from this interview and the API Innovation Center’s published reports.

The post Active Pharmaceuticals Ingredients Innovation Center (APIIC) is Reshoring a Vital Industry and Restoring Health Security appeared first on EQ.

Mike Fabrizi

TGI’s Generative AI for Geospatial Challenge Kickoff Event was Really Good: 7 Reasons Why 

1 month ago

The Taylor Geospatial Institute's recent "Generative AI for Geospatial Challenge" kickoff conference highlighted a crucial transformation: geospatial technology is no longer just for experts.

Once the domain of technical specialists with security clearances, the field is becoming accessible to everyone through innovations like "Queryable Earth" and "Digital Twins."

This democratization, powered by generative AI, arrives at a perfect moment for St. Louis, which has invested heavily in becoming a geospatial hub.

The shift from expertise-driven to accessibility-focused could be key to realizing the city's ambitions in the sector.

The post TGI’s Generative AI for Geospatial Challenge Kickoff Event was Really Good: 7 Reasons Why  appeared first on EQ.

Jonathan Allen

Mission Control Acquired by LeagueSpot

1 month 3 weeks ago

The co-founders celebrating an exit are SLU student alums who joined the St. Louis startup ecosystem following graduation. In our view, this acquisition news reflects well on the city's ongoing efforts to develop a student-to-startup pipeline that retains talent in the region.

The post Mission Control Acquired by LeagueSpot appeared first on EQ.

Jonathan Allen

Shared Services in the St. Louis AgTech and BioTech Innovation Districts

5 months 3 weeks ago

EQ's resident expert in economic complexity theory, Mike Fabrizi, explains the different shared services offered by St. Louis' innovation districts. From lab equipment to utilities management, shared services cuts down on outsourcing costs and increases the chance of your AgTech or BioTech startup succeeding in these resource intensive sectors.

The post Shared Services in the St. Louis AgTech and BioTech Innovation Districts appeared first on EQ.

Mike Fabrizi

Remembering Our Beloved Community Builder, Patty Hagen

6 months 2 weeks ago

My own experience as a coworking member (three years, 2016-2019) and the reflections of other T-REX associates have much in common.

Patty Hagen, T-REX’s Executive Director, is integral to our collective memory and she stands out as our community builder. We owe her memory both affection and gratitude. Here, we stop for a moment to pay our respects.

The post Remembering Our Beloved Community Builder, Patty Hagen appeared first on EQ.

Jonathan Allen

T-REX “Makes Hard Decision” to Solve Overly Complicated Legacy of Organization Names

8 months ago

For those aware of T-REX's history of operating under many names, the potential for confusion around their name seems patently obvious. So, it comes as no surprise that the organization chose today, the First April of the Month, to rebrand the organization.

The post T-REX “Makes Hard Decision” to Solve Overly Complicated Legacy of Organization Names appeared first on EQ.

Jonathan Allen

Big Pharma Teams Up with St. Louis Immunotherapy Startup & Why it Matters

10 months 2 weeks ago

Immunophotonics has announced a research collaboration with the innovation subsidiary of a major pharmaceutical company to study the effect of combining an immunotherapy drug with routine treatments for cancer in order to reduce the risk of recurrence. EQ speaks to the STL startup founder and explains 4 reasons why this is good news for St. Louis.

The post Big Pharma Teams Up with St. Louis Immunotherapy Startup & Why it Matters appeared first on EQ.

Jonathan Allen

Big Pharma Teams Up with St. Louis Vaccine Startup & Why it Matters

10 months 2 weeks ago

Omniose, a St. Louis biotech startup focused on developing vaccines for bacterial infections, has entered into a 3-year research agreement with AstraZeneca, the gigantic pharmaceutical firm known for developing Britain’s COVID-19 vaccine. EQ speaks to the STL startup founder and explains 2 reasons why this is good news for St. Louis.

The post Big Pharma Teams Up with St. Louis Vaccine Startup & Why it Matters appeared first on EQ.

Jonathan Allen